$MBIO News Article - Mustang Bio Announces Phase 1
Post# of 88977
(Total Views: 83)
Posted On: 10/27/2022 1:55:52 PM
$MBIO News Article - Mustang Bio Announces Phase 1/2 Clinical Trial Data of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy, to be Presented at 11th International Workshop for Waldenstrom's Macroglobulinemia https://marketwirenews.com/news-releases/must...60682.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼